TR79
TR79 is a mitochondrial ClpP protease activator with an EC50 of 414.49 nM. TR79 competitively occupies the ClpP binding site and attenuates MTP-B1-induced POLRMT degradation. TR79 can be used in research on mitochondria-related diseases (such as cancer and neurodegenerative diseases) and mitochondrial metabolic abnormalities.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2365073-59-0
- Fòrmula: C26H26F3N5O2
- Peso molecular:497.51
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
In Vitro
TR79 is a potent ClpP agonist, with an EC50 of 414.49 nM in the ClpP activation assay[1].
TR79 competitively occupies the ClpP binding site and attenuates MTP-B1-induced POLRMT degradation in cultured cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 2365073-59-0
-
Peso molecular 497.51
-
Fòrmula C26H26F3N5O2
-
SMILES
NCCCN(C1=C(CN(CC2=CC=CC(C#N)=C2)CC1)C(N3CC4=CC=C(C(F)(F)F)C=C4)=O)C3=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Chen C, et al. Development of High-Efficiency Mitochondrial Protease Targeting Chimeras (MtPTACs) for Targeted Degradation of POLRMT and Beyond. JACS Au. 2026 Sep 28;6(9):5439-5454. [Content Brief]
[2]. Yamada W, et al. Targeted protein degradation in the mitochondrial matrix and its application to chemical control of mitochondrial morphology. Chem Sci. 2024 Aug 28;15(36):14625-14634. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)